Long-acting injectable PrEP gives people another way to prevent HIV without taking a daily pill. PrEP means pre-exposure prophylaxis: medicine used before possible HIV exposure to lower the chance of infection. The two main injectable options are cabotegravir, given every two months after the first two doses, and lenacapavir, given every six months after starter dosing. Both are highly effective when taken on schedule, but they are not casual “set it and forget it” shots. They require HIV testing, follow-up visits, planning for missed appointments, and attention to side effects and drug interactions.
For men who struggle with daily pills, want more privacy, travel often, or have kidney issues that make some oral PrEP options harder to use, injections can be a major improvement. The right choice depends on risk, access, timing, medical history, and how reliably injection visits fit into real life.
Table of Contents
- How Injectable PrEP Works
- Cabotegravir vs Lenacapavir
- Timing, Schedules, and Missed Doses
- Testing Before and During PrEP
- Side Effects and Safety Issues
- Who Might Benefit Most
- Stopping, Switching, and the Drug Tail
- Questions to Ask Before Starting
How Injectable PrEP Works
Injectable PrEP keeps anti-HIV medicine in the body for weeks or months at a time. If HIV is encountered during sex, the medicine can block the virus from establishing infection. The protection depends on having enough drug in the body at the right time, which is why the injection schedule matters.
Cabotegravir is an integrase strand transfer inhibitor. It blocks a step HIV needs to insert its genetic material into human cells. Lenacapavir is a capsid inhibitor. It interferes with the HIV capsid, the protective shell involved in several stages of the viral life cycle. The details are different, but the goal is the same: stop HIV before infection takes hold.
Injectable PrEP is used before exposure. It is not PEP, which is emergency medicine taken after a possible HIV exposure. If a condom breaks, a partner later says they have untreated HIV, or you have another urgent exposure and are not already protected by PrEP, emergency care may still be needed.
PrEP also does not prevent chlamydia, gonorrhea, syphilis, herpes, HPV, or other sexually transmitted infections. Some men use injectable PrEP along with condoms, regular STI testing, and, in select situations, DoxyPEP for STI prevention. Those tools do different jobs, so one does not replace all the others.
Injectable PrEP may be especially helpful when daily pill-taking is hard. Missed daily pills can lower protection. Missed injection visits can also lower protection, but the schedule is less frequent and easier for some people to follow.
Cabotegravir vs Lenacapavir
Cabotegravir and lenacapavir are both long-acting injections, but they are not interchangeable. They differ in dosing interval, injection location, starter dosing, missed-dose plans, and drug interaction concerns.
| Feature | Cabotegravir | Lenacapavir |
|---|---|---|
| Common U.S. brand name | Apretude | Yeztugo |
| Medicine class | Integrase inhibitor | Capsid inhibitor |
| Injection type | Intramuscular injection into the buttock | Subcutaneous injections, usually into the abdomen or thigh |
| Usual schedule after start | Every 2 months | Every 6 months |
| Starter dosing | First injection, second injection 1 month later, then every 2 months | Two injections plus oral tablets on Day 1, oral tablets on Day 2, then injections every 6 months |
| Optional oral lead-in | Sometimes used for about 1 month to check tolerability | Not the same approach; oral tablets are part of required starter dosing |
| Main practical advantage | Long track record and every-other-month routine | Only two injection visits per year after initiation |
Cabotegravir has been used as the main injectable PrEP option for several years. It can be a good fit for men who want a clinic-based routine but are comfortable coming in every two months. Because it is injected into muscle, soreness in the buttock is common, especially after early doses.
Lenacapavir is newer as PrEP and lasts longer between injections. That six-month interval may appeal to people who want fewer visits, have privacy concerns, live far from a clinic, or have schedules that make frequent appointments difficult. The tradeoff is that getting off schedule requires careful planning because the dosing window is wider but not unlimited.
Daily oral PrEP still works very well for many men. Pills may be easier for someone who dislikes injections, travels unpredictably, wants easier stop-start control, or cannot access a clinic that offers long-acting products. A broader comparison of pills and shots is covered in HIV PrEP for men.
Timing, Schedules, and Missed Doses
The injection schedule is part of the treatment. A late dose is not just an appointment problem; it can create a period when drug levels are lower than intended.
Cabotegravir usually starts with two initiation injections one month apart. After that, injections continue every two months. There is generally a short window around the scheduled date, but if the visit will be missed by more than about a week, the prescriber may use oral cabotegravir or another PrEP option to cover the gap.
Lenacapavir starts with both injections and tablets. On Day 1, the person receives two subcutaneous injections and takes oral tablets. On Day 2, oral tablets are taken again. After that, injections are given every six months, counted from the last injection date. If a six-month injection will be delayed beyond the allowed window, weekly oral tablets may be used temporarily under the prescriber’s plan.
| Situation | Why it matters | What to discuss |
|---|---|---|
| Travel or seasonal work | You may be away when the next injection is due | Whether to schedule early, use temporary oral medicine, or switch PrEP methods |
| Changing insurance | Missed coverage can interrupt appointments | Prior authorization, copay programs, and backup oral PrEP |
| Unpredictable sex risk | Stopping and restarting needs planning | Whether injections or pills match your pattern better |
| Privacy concerns | Clinic visits, pharmacy records, or reminders may be visible | Confidential communication and discreet appointment systems |
Do not guess your own catch-up dose. Long-acting medicines stay in the body for a long time, and restart rules can depend on how late the dose is, whether oral backup was used, and whether HIV testing is still clearly negative.
Men who travel often should plan injection dates before booking long trips. Put the next due date in two places, such as your phone calendar and the clinic’s reminder system. If a trip, deployment, school break, or work rotation overlaps with the due date, call early rather than waiting until after the dose is late.
Testing Before and During PrEP
HIV testing is required before starting injectable PrEP and before ongoing injections. The reason is simple: PrEP medicines are not full HIV treatment. If someone already has early HIV infection and receives only one PrEP medicine, the virus may become harder to treat.
Early HIV can be easy to miss. Symptoms may feel like flu, COVID, mono, or no illness at all. Fever, swollen glands, rash, sore throat, night sweats, diarrhea, or body aches after a recent exposure should be mentioned before any injection. A standard rapid test may not always be enough if exposure was recent, so clinicians may order lab-based antigen/antibody testing and sometimes HIV RNA testing.
Testing also includes other infections and health checks. Men using PrEP should be screened for STIs based on the types of sex they have. That may mean urine, throat, and rectal tests, not just a urine sample. Timing matters after exposure, and when to get STI tested depends on the infection and the body site being checked.
Typical follow-up may include:
- HIV testing before each injection
- STI testing at regular intervals, often every 3 to 6 months depending on risk
- Review of symptoms that could suggest recent HIV infection
- Medication review for drug interactions
- Pregnancy testing when relevant for the patient
- Kidney or hepatitis testing when oral PrEP or other health issues make it relevant
Men sometimes avoid testing because they feel well. That is risky. Many STIs can be silent, especially rectal or throat infections. Untreated infections can spread to partners and sometimes cause complications. At-home tests can help with privacy and access, but they do not replace the HIV testing required before injectable PrEP doses. For STI screening outside clinic visits, at-home STI tests for men can be useful when the test matches the exposure site and timing.
Side Effects and Safety Issues
Injection site reactions are the most common side effect with long-acting injectable PrEP. They may include pain, tenderness, swelling, redness, firmness, itching, bruising, or a small lump. These reactions are usually mild to moderate and often improve after the first doses, but some people find them annoying enough to reconsider the method.
Cabotegravir injections go into the buttock muscle. Soreness can last a few days. Some people also report headache, fever, tiredness, nausea, sleep changes, dizziness, rash, or muscle aches. Serious allergic reactions are uncommon but need urgent attention.
Lenacapavir injections are placed under the skin. Because the medicine forms a depot that releases slowly, small nodules or firmness can happen and may last longer than a typical vaccine-site bump. Other possible effects include nausea, headache, and local skin reactions.
Call a clinician urgently if you develop a widespread rash, blisters, mouth sores, facial swelling, trouble breathing, yellowing of the skin or eyes, severe abdominal pain, or symptoms that feel like a serious allergic reaction. Also report symptoms of possible new HIV infection before receiving another injection.
Drug interactions are important. Cabotegravir can interact with certain seizure medicines and tuberculosis medicines, including some strong enzyme inducers. Lenacapavir also has interaction concerns, especially with medicines that affect CYP3A, P-gp, or related pathways. Bring a complete medication list, including supplements, bodybuilding drugs, antibiotics, seizure medicines, tuberculosis treatment, and over-the-counter products.
Men using anabolic steroids, SARMs, or non-prescribed hormones should be honest with the clinician. The issue is not judgment; it is safety. Unknown or unlisted substances can complicate liver tests, mood symptoms, sexual health, and medication interactions.
Injectable PrEP is not a substitute for safer-sex planning. Condoms still reduce the risk of many STIs and can help prevent pregnancy with partners who can become pregnant. Fit, lubrication, and correct use matter; common errors are covered in condoms and men’s health.
Who Might Benefit Most
Injectable PrEP is often a strong option for men who want HIV protection but do not want a daily pill. That may include men who forget doses, have irregular routines, dislike pill bottles, worry about privacy, or feel anxious about whether they took a dose before sex.
It may also help men with kidney disease who cannot use certain tenofovir-based oral PrEP pills. Cabotegravir, in particular, has been useful for people who need to avoid oral PrEP because of kidney concerns. Lenacapavir also offers a non-daily option, though final choice depends on the full medical picture and local prescribing rules.
Men at higher HIV risk may include those who have condomless anal sex with partners whose HIV status is unknown, partners with untreated or detectable HIV, recent bacterial STIs, multiple partners, sex with partners from higher-prevalence networks, or sex while using substances that make condom use less consistent. Risk is not a label or identity; it is about exposure patterns.
Injectable PrEP may be less convenient for someone who cannot reliably attend clinic visits. A man who can take pills daily but often misses appointments may be better protected with oral PrEP than with late injections. The best method is the one that can be used correctly.
Think about daily life, not only medical preference:
- Can you attend visits on schedule?
- Will transportation, work, school, or caregiving interfere?
- Do you need privacy from family, roommates, or a partner?
- Are you comfortable with injections and possible soreness?
- Do you travel for more than a few weeks at a time?
- Would oral backup be realistic if an injection is delayed?
A man with a predictable calendar may do well with cabotegravir every two months. A man who lives far from a clinic may prefer lenacapavir every six months. A man whose HIV risk comes and goes in short periods may prefer oral PrEP because starting and stopping can be more flexible.
Sexual exposure site also matters for STI testing. Oral sex can still transmit some infections even when HIV risk is lower than with anal sex. Men who want a fuller prevention plan should understand oral sex and STI risks, especially when throat testing is often skipped.
Stopping, Switching, and the Drug Tail
Long-acting injections fade slowly. This period is sometimes called the “drug tail.” Drug levels can remain in the body after the protection is no longer reliable. During that tail, if someone is exposed to HIV, there is a concern that infection could occur while low levels of medicine are present, which may increase the risk of drug resistance.
Stopping injectable PrEP should be planned, not improvised. If you still have HIV risk, your clinician may recommend switching to oral PrEP or another prevention method before protection drops too low. The timing depends on the injection used, the date of the last dose, and whether you will continue to have possible exposure.
Switching from injections to pills can be straightforward when planned ahead. It becomes more complicated when a person misses visits, cannot be reached, or stops because of insurance or access problems. Clinics often try to schedule the next appointment before you leave because missed follow-up is one of the biggest weak points of long-acting prevention.
Reasons to stop or switch may include:
- Side effects that do not improve
- Loss of insurance coverage or high out-of-pocket cost
- Moving away from the clinic
- A period of no ongoing HIV risk
- Preference for pills, condoms, or another method
- New medication interactions
- New HIV diagnosis, which requires full HIV treatment instead of PrEP
If you test positive for HIV while using PrEP, do not take more PrEP doses unless an HIV specialist tells you to. Full HIV treatment uses a combination of medicines. Prompt treatment protects your health and lowers the chance of passing HIV to partners once viral load becomes undetectable.
Do not stop showing up for testing just because you stopped injections. Follow-up HIV testing after the last injection may still be needed, especially if you had ongoing exposure or missed doses.
Questions to Ask Before Starting
A good PrEP visit should leave you knowing the schedule, the testing plan, the backup plan, and what to do if something changes. If any of those are unclear, ask before the first injection.
Useful questions include:
- Which injectable option fits my risk pattern and schedule best?
- What HIV test will I need before each injection?
- What symptoms should make me delay an injection and call first?
- How soon do I need to contact you if I will miss an appointment?
- What oral medicine would I use if I travel or miss a dose?
- Which side effects are common, and which are urgent?
- Do any of my medicines or supplements interact with this option?
- How often should I get urine, throat, and rectal STI testing?
- What happens if my insurance changes?
- How do we safely stop or switch methods later?
Bring real details about your sex life. A clinician does not need a perfect story, but they do need enough information to choose the right tests and prevention plan. Mention condom use, receptive or insertive anal sex, oral sex, recent STIs, partners with HIV, partners whose status you do not know, and any recent exposure that worries you.
Cost and access can affect the decision as much as medicine. Injectable PrEP may require prior authorization, clinic administration fees, specialty pharmacy coordination, and reliable follow-up. Ask who handles insurance approval and what happens if a dose is due before approval is complete.
A strong plan is simple: test before dosing, get injections on time, screen for STIs, have a missed-dose plan, and reassess risk regularly. Injectable PrEP can be highly protective, but the protection comes from the whole system around it, not the injection alone.
References
- Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis — United States, 2025 2025 (Guideline)
- Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis 2025 (Guideline)
- Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons 2024 (RCT)
- Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women 2024 (RCT)
- Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women 2021 (RCT)
- DailyMed – YEZTUGO- lenacapavir sodium tablet, film coated YEZTUGO- lenacapavir sodium kit 2026 (Prescribing Information)
Disclaimer
This article is educational and does not replace care from a qualified healthcare professional. Injectable PrEP requires HIV testing, prescription review, and follow-up dosing from a clinician. Seek medical advice promptly after a possible HIV exposure, symptoms of acute HIV, severe side effects, or a missed injection.
